Literature DB >> 2912901

Ceruloplasmin can substitute for rabbit serum in stimulating the growth of Treponema denticola.

M Suzuki1, W J Loesche.   

Abstract

The growth of Treponema denticola in a complex medium was stimulated by human ceruloplasmin and, to a lesser extent, albumin, alpha-1-antitrypsin, alpha-1-acid glycoprotein, and alpha-2-macroglobulin. Human ceruloplasmin could stimulate growth of T. denticola as well as or better than 5% rabbit serum, with a dose-response relationship of between 1 and 5 mg of ceruloplasmin per ml of culture medium. These results suggest that ceruloplasmin could substitute for rabbit serum in stimulating the growth of T. denticola.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912901      PMCID: PMC313147          DOI: 10.1128/iai.57.2.643-644.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  4 in total

1.  Replacement of ascitic fluid or rabbit serum requirement of Treponema dentium by alpha-globulin.

Authors:  S S Socransky; C Hubersak
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

2.  Purification and characterization of an enzyme produced by Treponema denticola capable of hydrolyzing synthetic trypsin substrates.

Authors:  K Ohta; K K Makinen; W J Loesche
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

3.  Nutrient and environmental growth factors for eight small-sized oral spirochetes.

Authors:  N E Fiehn; J Westergaard
Journal:  Scand J Dent Res       Date:  1986-06

4.  Purification of undegraded ceruloplasmin from outdated human plasma.

Authors:  M M Oosthuizen; L Nel; J A Myburgh; R L Crookes
Journal:  Anal Biochem       Date:  1985-04       Impact factor: 3.365

  4 in total
  1 in total

1.  Continuous activation of the IL-17F driven inflammatory pathway in acute and chronic digital dermatitis lesions in dairy cattle.

Authors:  Anne-Sofie Vermeersch; Peter Geldhof; Richard Ducatelle; Yannick Gansemans; Filip Van Nieuwerburgh; Dieter Deforce; Geert Opsomer
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.